Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer Treatment

NCT01489813 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: Genistein
DRUG: Sugar pill

Sponsor

Emory University

Collaborators

[object Object]
[object Object]
[object Object]